Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Inositol Metabolism | R-HSA-1483249 | 0 | Fe2+ | 439260 | smpdb |
Dihydropyrimidinase Deficiency | R-HSA-5602680 | 0 | Fe2+ | 439260 | smpdb |
Familial Hypercholanemia | R-HSA-5682111 | 0 | Fe2+ | 439260 | smpdb |
Zoledronate Action Pathway | R-HSA-9639775 | 0 | Fe2+ | 439260 | smpdb |
Congenital Bile Acid Synthesis Defect Type II | R-HSA-194068 | 0 | Fe2+ | 439260 | smpdb |
Congenital Erythropoietic Porphyria or Gunther Disease | 0 | 0 | Fe2+ | 439260 | smpdb |
Simvastatin Action Pathway | R-ALL-9705597 | 0 | Fe2+ | 439260 | smpdb |
Galactosemia | R-HSA-5610038 | 0 | Fe2+ | 439260 | smpdb |
Tryptophan Metabolism | R-HSA-71240 | map00380 | Fe2+ | 439260 | smpdb |
Congenital Disorder of Glycosylation CDG-IId | R-HSA-5619078 | 0 | Fe2+ | 439260 | smpdb |
Fluvastatin Action Pathway | R-ALL-9705591 | 0 | Fe2+ | 439260 | smpdb |
Chondrodysplasia Punctata II, X-Linked Dominant | 0 | 0 | Fe2+ | 439260 | smpdb |
Porphyrin Metabolism | R-ALL-1369066 | map00860 | Fe2+ | 439260 | smpdb |
Refsum Disease | R-HSA-1643685 | 0 | Fe2+ | 439260 | smpdb |
Wolman Disease | R-HSA-1643685 | 0 | Fe2+ | 439260 | smpdb |
Cystinosis, Ocular Nonnephropathic | R-HSA-5619054 | 0 | Fe2+ | 439260 | smpdb |
Desmosterolosis | R-HSA-196417 | 0 | Fe2+ | 439260 | smpdb |
27-Hydroxylase Deficiency | R-HSA-5602680 | 0 | Fe2+ | 439260 | smpdb |
The Oncogenic Action of Fumarate | R-HSA-6802957 | 0 | Fe2+ | 439260 | smpdb |
Aromatic L-Aminoacid Decarboxylase Deficiency | R-HSA-2167848 | 0 | Fe2+ | 439260 | smpdb |